Shopping Cart
- Remove All
Your shopping cart is currently empty
hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50 values of 1.18 μM for hCA II, 0.17 μM for hCA IX, and 2.99 μM for hCA XII. It is not blood-brain barrier permeable.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $30 | In Stock | |
| 5 mg | $62 | In Stock | |
| 10 mg | $90 | In Stock | |
| 25 mg | $153 | In Stock | |
| 50 mg | $232 | In Stock | |
| 100 mg | $333 | In Stock | |
| 200 mg | $488 | In Stock |
| Description | hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50 values of 1.18 μM for hCA II, 0.17 μM for hCA IX, and 2.99 μM for hCA XII. It is not blood-brain barrier permeable. |
| Targets&IC50 | CA IX (human):0.17 μM, CA XII (human):2.99 μM, CA II (human):1.18 μM |
| In vitro | HCAII-IN-9 (Compound 11) (100 μM; 24-48 h) inhibits BHK-21 and HEK-293 cells with cell viability of 48% and 72%, respectively.[1] |
| Molecular Weight | 417.89 |
| Formula | C15H16ClN3O5S2 |
| Cas No. | 2878477-18-8 |
| Smiles | S(N)(=O)(=O)C1=C(NC(=O)C2=CC(C)=CC(C)=C2)C=C(Cl)C(S(N)(=O)=O)=C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (131.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.